Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Ophiobolin B | C25H38O4 | 5601-74-1 | Details |
| Erdosteine | C8H11NO4S2 | 84611-23-4 | Details |
| O-Methyl Atorvastatin hemicalcium | C67H68Ca2F2N4O10 | 887196-29-4 | Details |
| Ilginatinib maleate | C25H24FN7O4 | 1354799-87-3 | Details |
| Olcegepant hydrochloride；BIBN-4096 hydrochloride;BIBN4096BS hydrochloride | C38H48Br2ClN9O5 | 586368-06-1 | Details |
| Oxidopamine hydrochloride | C8H12ClNO3 | 28094-15-7 | Details |
| Orelabrutinib | C26H25N3O3 | 1655504-04-3 | Details |
| Opioid receptor modulator 1 | C18H23NO2 | 77514-44-4 | Details |
| Oral antiplatelet agent 1 | C23H24N4O5S | 2299200-91-0 | Details |
| Cefuroxime axetil | C20H22N4O10S | 64544-07-6 | Details |
| OR-1896 | C13H15N3O2 | 220246-81-1 | Details |
| Ilginatinib hydrochloride | C21H21ClFN7 | 1239358-85-0 | Details |
| OP-1074 | C29H31NO4 | 1443752-76-8 | Details |
| Oleoylethanolamide | C20H39NO2 | 111-58-0 | Details |
| OMDM-6 | C28H42N2O3 | 616884-67-4 | Details |
| Oxythiamine diphosphate | C12H17N3O8P2S | 10497-04-8 | Details |
| p53 and MDM2 proteins-interaction-inhibitor (chiral)；p53-and-mdm2-proteins-interaction-inhibitor-chiral | C40H49Cl2N5O4 | 939981-37-0 | Details |
| Omeprazole-d3；H 16868 D3;Omeprazole D3 | C17H16D3N3O3S | 922731-01-9 | Details |
| Oxidopamine hydrobromide | C8H12BrNO3 | 636-00-0 | Details |
| NSC305787 hydrochloride | C25H31Cl3N2O | 53868-26-1 | Details |
| Pamabrom | C11H18BrN5O3 | 606-04-2 | Details |
| Ebopiprant | C30H34FN3O5S2 | 2005486-31-5 | Details |
| OMDM-3 | C29H43NO3 | 616884-64-1 | Details |
| OSMI-3 | C32H35N3O9S2 | 2260791-13-5 | Details |
| Benzyl-α-GalNAc | C15H21NO6 | 3554-93-6 | Details |
| Oleuropeinic acid | C25H30O15 | 96382-90-0 | Details |
| ORM-15341 | C19H17ClN6O2 | 1297537-33-7 | Details |
| 5,5-Dimethyloxazolidine-2,4-dione | C5H7NO3 | 695-53-4 | Details |
| OTS186935 | C25H26ClN5O2 | 2093400-18-9 | Details |
| Siremadlin (R Enantiomer)；HDM201 R Enantiomer;NVP-HDM201 R Enantiomer;Siremadlin R Enantiomer | C26H24Cl2N6O4 | 1448867-42-2 | Details |
| CBP/p300-IN-5；P300/CBP-IN-5 | C29H27F5N6O4 | 1889284-33-6 | Details |
| Mepyramine maleate | C21H27N3O5 | 59-33-6 | Details |
| Pilocarpine nitrate | C11H17N3O5 | 148-72-1 | Details |
| NVP-QAV-572 | C17H19F2N7O3S2 | 957209-68-6 | Details |
| Oleoylcarnitine | C25H47NO4 | 38677-66-6 | Details |
| NXT629 | C35H39N5O3S | 1454925-59-7 | Details |
| OT antagonist 3 | C21H20N6O2 | 925703-75-9 | Details |
| ODM-204 | C20H21F3N4 | 1642818-64-1 | Details |
| Lincomycin hydrochloride monohydrate | C18H37ClN2O7S | 7179-49-9 | Details |
| NVS-CRF38 | C19H21N5O2 | 1207258-55-6 | Details |
| Olanzapine D3；LY170053 D3 | C17H20N4S | 786686-79-1 | Details |
| OXFBD04 | C17H16N2O3 | 2231747-03-6 | Details |
| NTP42 | C25H23F2N3O5S | 2055599-51-2 | Details |
| Odapipam；NNC 756 | C19H20ClNO2 | 131796-63-9 | Details |
| OT-R antagonist 1；Oxytocin receptor antagonist 1 | C28H29N3O4 | 364071-17-0 | Details |
| Oligomycin B | C45H72O12 | 11050-94-5 | Details |
| Oxotremorine M iodide | C11H19IN2O | 3854-04-4 | Details |
| Oxythiamine；Hydroxythiamin | C12H17Cl2N3O2S | 136-16-3 | Details |
| OMDM-2 | C27H45NO3 | 616884-63-0 | Details |
| ARRY-797 | C22H26F2N4O2 | 1034189-82-6 | Details |
| P-gp inhibitor 1 | C32H31N5O2 | 2050747-49-2 | Details |
| Cefonicid sodium；Monocid sodium;Cefonicid disodium salt | C18H19N6NaO8S3 | 61270-78-8 | Details |
| Palbinone | C22H30O4 | 139954-00-0 | Details |
| O-Desmethyl apixaban | C24H23N5O4 | 503612-76-8 | Details |
| NSC624206 | C19H33Cl2NS2 | 13116-77-3 | Details |
| p38-α MAPK-IN-1 | C27H35N5O3 | 443913-15-3 | Details |
| OICR-0547 | C28H29F3N4O4 | 1801873-49-3 | Details |
| ORL1 antagonist 1 | C20H22ClN5 | 1174985-59-1 | Details |
| OM-189 | C24H36N6O3S | 55381-18-5 | Details |
| NVS-ZP7-4 | C28H28FN5OS | 2349367-89-9 | Details |
| OT antagonist 1 | C22H22N4O3 | 479080-38-1 | Details |
| Oxolinic acid | C13H11NO5 | 14698-29-4 | Details |
| O-Propargyl-Puromycin | C24H29N7O5 | 1416561-90-4 | Details |
| ON 146040 | C24H23N7O3S | 1404231-34-0 | Details |
| Ilginatinib | C21H20FN7 | 1239358-86-1 | Details |
| Omeprazole metabolite Omeprazole sulfone | C17H19N3O4S | 88546-55-8 | Details |
| OMDM-5 | C26H44N2O3 | 616884-66-3 | Details |
| OTS186935 trihydrochloride | C25H27Cl2N5O2 | 2093401-85-3 | Details |
| p53 and MDM2 proteins-interaction-inhibitor (racemic)；p53-and-mdm2-proteins-interaction-inhibitor-racemic | C40H49Cl2N5O4 | 939983-14-9 | Details |
| Tirabrutinib hydrochloride | C25H23ClN6O3 | 1439901-97-9 | Details |
| Octadecanedioic acid | C18H34O4 | 871-70-5 | Details |
| NUCC-390 | C23H33N5O | 1060524-97-1 | Details |
| OSMI-2 | C26H25N3O7S2 | 2260542-60-5 | Details |
| Org30958 | C21H30O2S2 | 99957-90-1 | Details |
| ORM-10103 | C20H16N2O4 | 488847-28-5 | Details |
| NVP-CGM097 sulfate；CGM097 sulfate | C38H49ClN4O8S | 1313367-56-4 | Details |
| OT-R antagonist 2；Oxytocin receptor antagonist 2 | C28H29N3O4 | 364071-16-9 | Details |
| Org-10490 | C17H19NO | 83507-02-2 | Details |
| Orotic acid-6-C14 | C5H4N2O4 | 13186-54-4 | Details |
| NV-5138 | C7H13F2NO2 | 2095886-80-7 | Details |
| O-Desmethyl Midostaurin；O-Desmethyl PKC412;CGP62221 | C34 H28 N4 O4 | 740816-86-8 | Details |
| P-gp modulator 1 | C41H72N2O6 | 2249749-39-9 | Details |
| Ornidazole (Levo-) | C7H10ClN3O3 | 166734-83-4 | Details |
| CBP/p300-IN-3 | C24H29N7O | 2299226-01-8 | Details |
| OT-82 | C26H21FN4O | 1800487-55-1 | Details |
| OMDM-4 | C29H43NO3 | 616884-65-2 | Details |
| OSMI-4 | C27H26ClN3O7S2 | 2260791-14-6 | Details |
| ORM-10962 | C27H29N3O4 | 763926-98-3 | Details |
| Oligomycin C | C45H74O10 | 11052-72-5 | Details |
| Olaparib-d5；Olaparib D5;KU0059436 D5;AZD2281 D5 | C24H23FN4O3 | 2143107-56-4 | Details |
| Fludazonium chloride | C26H20Cl4FN2O2*Cl | 53597-28-7 | Details |
| Oxaquin；MCB-3837;DNV3837 | C31H33F2N4O11P | 790704-50-6 | Details |
| Obtusifoliol | C30H50O | 16910-32-0 | Details |
| Olcegepant | C38H47Br2N9O5 | 204697-65-4 | Details |
| Oleanolic acid hemiphthalate disodium salt | C38H53NaO6 | 168770-31-8 | Details |
| NSC305787 | C25H30Cl2N2O | 785718-37-8 | Details |
| Benzquinamide；BZQ;Benzoquinamide;P2647 | C22H32N2O5 | 63-12-7 | Details |
| OMDM-1；(Z)-N-[(2S)-1-hydroxy-3-(4-hydroxyphenyl)propan-2-yl]octadec-9-enamide | C27H45NO3 | 616884-62-9 | Details |
| Olmesartan-d4；RNH-6270 D4;Olmesartan D4 | C24H22N6O3D4 | 1420880-41-6 | Details |
| NSP-805 | C17H19N3O2 | 125068-54-4 | Details |
| Product Total： Product Page： | ||||
| 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 | ||||